Mar 6
|
CytoSorbents to Report Fiscal 2023 Operating and Financial Results
|
Dec 18
|
Insider Spends US$100k Buying More Shares In Cytosorbents
|
Dec 13
|
CytoSorbents Announces Closing of $10.3 Million Registered Direct Offering
|
Sep 1
|
CytoSorbents Announces Resignation of Chief Financial Officer Alexander D’Amico
|
Aug 31
|
CytoSorbents Granted Expanded ANVISA Registration to Treat Shock with CytoSorb in Brazil
|
Apr 26
|
CytoSorbents to Report First Quarter 2023 Operating and Financial Results
|